Meitheal Pharmaceuticals is pleased to announce that Haloperidol Decanoate Injection is Now Available.
Meitheal Pharmaceuticals (Meitheal) is pleased to announce we have launched Haloperidol Decanoate Injection 50 mg per mL single dose vial, 100 mg per mL single dose vial and 500 mg per 5 mL (100 mg per mL) multi dose vial.
Meitheal will offer Haloperidol Decanoates Injection single dose preparations in carton of 10 vials and multi dose vials as a carton of 1 vial.
ABOUT HALOPERIDOL DECANOATE INJECTION
Haloperidol Decanoate Injection is indicated for the treatment of schizophrenic patients who require prolonged parenteral antipsychotic therapy. For full prescribing information, and safety information, including boxed warning, please click on the following link.
Learn more about who we are and what we do at www.meithealpharma.com.